Literature DB >> 29467579

Viral and Bacterial Etiologies of Acute Respiratory Infections Among Children Under 5 Years in Senegal.

Dieng Assane1, Camara Makhtar1, Diop Abdoulaye1, Fall Amary2, Boiro Djibril3, Diop Amadou5, Diouf Jean Baptiste Niokhor4, Diop Amadou5, Loucoubar Cheikh6, Dia Ndongo2, Niang Mbayame2, Fall Lamine7, Boye Cheikh Saad Bouh1.   

Abstract

Acute respiratory infections (ARIs) are the leading cause of infectious disease-related morbidity, hospitalization, and morbidity among children worldwide. This study aimed to assess the viral and bacterial causes of ARI morbidity and mortality in children under 5 years in Senegal. Nasopharyngeal samples were collected from children under 5 years who had ARI. Viruses and bacteria were identified using multiplex real-time reverse transcription-polymerase chain reaction and conventional biochemical techniques, respectively. Adenovirus was the most prevalent virus (50%; n = 81), followed by influenza virus (45.68%, n = 74), rhinovirus (40.12%; n = 65), enterovirus (25.31%; n = 41), and respiratory syncytial virus (16.05%; n = 26), whereas Streptococcus pneumoniae (17%; n = 29), Moraxella catarrhalis (15.43%; n = 25), and Haemophilus influenzae (8.02%; n = 13) were the most commonly isolated bacteria. Virus pathogens seem more likely to be more prevalent in our settings and were often associated with bacteria and S. pneumoniae (6%; 16) coinfection.

Entities:  

Keywords:  Acute respiratory tract infections; bacteria; children <5 years; virus

Year:  2018        PMID: 29467579      PMCID: PMC5815418          DOI: 10.1177/1178636118758651

Source DB:  PubMed          Journal:  Microbiol Insights        ISSN: 1178-6361


Introduction

Respiratory tract infections (RTIs) such as acute otitis media, sinusitis, bronchitis, and community-acquired pneumonia are a leading cause of infectious disease–related morbidity, hospitalization, and mortality among children worldwide, particularly in low-income countries.[1] According to World Health Organization (WHO), the prevalence of hospitalized children under 5 years with acute respiratory infections (ARIs) is estimated to be 20% and 90% of those were due to pneumonia.[2] In addition, the number of childhood deaths annually related to ARIs is very important and is estimated between 1.9 and 2.2 million, and 70% of the deaths took place in Africa and Southeast Asia which are the most.[1,3] Bacteria and viruses have been reported as the main causes of ARIs. In children under 5 years, ARIs are caused mainly due to viruses; respiratory syncytial viruses (RSVs), parainfluenza viruses, influenza virus A and B, and human metapneumovirus (hMPV) are the most common viruses isolated.[4,5] However, primary infections with viral pathogens can predispose to secondary bacterial infections, and the most frequently isolated bacteria in ARIs include Streptococcus pneumonia and Haemophilus influenzae.[6] These bacteria were increasingly resistant to the most commonly used antibiotics for ARI treatment,[7] leading to increase in mortality rates, hospital durations, and health care–associated costs.[8] In resource-limited countries, bacteria have been the main cause of ARIs. This could be explained by the inaccessibility of molecular diagnostic tools thus leading to inadequate antibiotics prescription and consequently contributed to a rapid increase in antimicrobial resistance among bacteria causing RTIs.[9,10] In Senegal, few studies on viral and bacterial etiologies of RTIs are available in pediatric settings. Respiratory tract infections are mainly empirically treated with antibiotics on a simple suspicion of bacterial infection. Indeed, this could be one of the major causes of high morbidity and mortality rates. The aim of this study was to investigate the viral and/or bacterial infections associated with ARIs in children under 5 years.

Materials and Methods

Recruitment and samples

This study was conducted between January 2015 and January 2016 at the Albert Royer Paediatric hospital, the Roi Baudouin Hospital, and the Abass Ndao Hospital, all located in Dakar, Senegal. Inclusion criteria were as follows: children aged under 5 years attending with an upper or lower airway infection. Bronchoalveolar lavage, sinus fluids, and throat swab samples were collected and referred to the biotechnology unit of the laboratory of bacteriology and virology of Aristide Le Dantec and to the virology unit of Pasteur Institute. This study has been approved by the Ethics Committee for Research of the Cheikh Anta DIOP University of Dakar. Samples and information for questionnaires have been collected after patient’s informed consent.

Identification of bacterial isolates

Bacteria were isolated from appropriate culture media and incubation conditions prior identification following microbiological standard procedures based on morphological, cultural, and biochemical or antigenic characters. Strains were identified if the bacterial load was at least 105 CFUs/mL.

Nucleic acid extraction and viral detection

Total viral nucleic acid (DNA and RNA) was extracted from 140 μL of each clinical specimen using the PureLink Viral RNA/DNA Mini Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s recommendations. DNA/RNA was eluted with 60 μL nuclease-free water and stored at −80°C until use. A 2-step multiplex real-time reverse transcription-polymerase chain reaction was performed with a Bio-Rad CFX-96 thermo cycler (Bio-Rad Laboratories, Singapore) and the Anyplex II RV16 Detection Kit (Seegene, Seoul, Korea) for a simultaneous testing of influenza viruses (fluA and fluB), human respiratory syncytial virus (RSVA and RSVB), human adenoviruses (HAdV), HMPV, human coronavirus (229E, NL63, OC43), human parainfluenza virus (PIV1, 2, 3, and 4), human rhinovirus (HRV), human enterovirus (HEV), and human bocavirus (HBoV).

Statistical analysis

Data were analyzed using R statistical software version 3.3.1.[11]

Results

Over a period 1 year, 162 children with ARIs were included in this study including 97 (59.9%) men. Overall, 30 children were under 6 months of age, 26 were 6 to 12 months old, 31 were 12 to 24 months old, 53 were 24 to 60 months old, and 23 were 60 to 112 months old. Table 1 shows the distribution of major viruses isolated during this study period, the frequency of single or coinfection, and the number of infections stratified by age group.
Table 1.

Distribution of virus and number of coinfections stratified by age group.

VirusNo. of coinfections, No. (%)
Total no. of infections/age group, mo
Total no. of infections
Single infection
VirusesBacteriaMixed (virus + bacteria)Mean age of infected children, y0-66-1212-2424-6060-112
No. (%)No. (%)
Adenovirus81 (50)6 (3.7)41 (25.31)8 (4.94)26 (16.05)2.12171120294
Influenza74 (45.68)0 (0)54 (33.33)0 (0)20 (12.35)2.5315720239
Rhinovirus65 (40.12)3 (1.85)40 (24.69)7 (4.32)15 (9.26)1.96181015175
SRV26 (16.05)0 (0)23 (14.2)0 (0)3 (1.85)1.29106451
Enterovirus41 (25.31)3 (1.85)31 (19.14)1 (0.62)6 (3.7)2.11887144
Distribution of virus and number of coinfections stratified by age group. Among selected virus species, adenovirus was the most prevalent (50%, n = 81), followed by influenza virus (45.68%, n = 74), rhinovirus (40.12%, n = 65), enterovirus (25.31%, n = 41), and RSV (16.05%, n = 26). Single infection with adenovirus was very rare (3.7%, n = 6). However, adenovirus was associated with other viruses and bacteria in 25.31% (n = 41) and 4.94% (n = 8), respectively. In addition, adenovirus/other viruses/bacteria coinfections have been detected in 16.05% (n = 26) of children. Influenza virus infections were associated with single-virus coinfections (33.3%, n = 54) or virus and bacteria coinfections (12.35%, n = 20). However, influenza virus single-infected children were not detected. Low prevalence of both rhinovirus and enterovirus single infections was observed (1.85%, n = 3). These infections were most often associated with single virus or virus and bacteria coinfections. Adenovirus, influenza virus, and enterovirus infections were more prevalent among children aged from 24 to 60 months. The prevalence of RSV infections associated with other viruses or other viruses and bacteria was 19.14% and 1.85%, respectively; however, no RSV single infection was detected. Children aged from 0 to 6 months were more likely to be more affected with rhinovirus and RSV infections. The distribution of major bacterial clinical strains is shown in Table 2. Among isolated bacterial species, S. pneumoniae was the most prevalent bacteria (17%) followed by M. catarrhalis (15.43%) and H. influenzae (8.02%).
Table 2.

Distribution of bacteria and number of coinfections by stratified age group.

BacteriaNo. of coinfections, No. (%)
Total no. of infections/age group, mo
No. of infections
Single infection
BacteriaVirusesMean age of infected children, y0-66-1212-2424-6060-112
No. (%)No. (%)
Haemophilus influenzae 13 (8.02)1 (0.62)0 (0)12 (7.4)2.5821361
Streptococcus pneumoniae 29 (17.9)2 (1.23)0 (0)27 (16.66)1.84751142
Moraxella catarrhalis 25 (15.43)2 (1.23)0 (0)23 (14.19)1.82341170
Other11 (6.79)4 (2.47)0 ()7 (4.32)2.0522160
Distribution of bacteria and number of coinfections by stratified age group. Bacterial single infections were also very rare: S. pneumoniae (2%), M. catarrhalis (2%), and H. influenzae (1%). No bacteria/bacteria coinfections were detected. However, coinfections with bacteria and viruses had been observed in children having ARIs and coinfection with S. pneumoniae (16.66%) was most frequent followed by M. catarrhalis (14, 19%) and H. influenzae (4.32%). The contribution of viral and bacterial pathogens to the clinical syndrome is depicted in Tables 3 and 4, respectively.
Table 3.

Contribution of viral pathogens to clinical syndrome.

DiagnosticsADVFLUHRVHEVVRS
Community pneumonia1310643
Acute bronchitis251621106
Bronchiolitis1291137
Rhinitis2028261010
Tonsillitis108880
Angina13360

Abbreviations: ADV, adenovirus; HEV, human enterovirus; HRV, human rhinovirus.

Table 4.

Contribution of bacterial pathogens to clinical syndrome.

Diagnostics Haemophilus influenzae Streptococcus pneumoniae Moraxella catarrhalis
Community pneumonia114
Acute bronchitis275
Bronchiolitis182
Acute otitis011
Rhinitis91210
Tonsillitis002
Angina001
Contribution of viral pathogens to clinical syndrome. Abbreviations: ADV, adenovirus; HEV, human enterovirus; HRV, human rhinovirus. Contribution of bacterial pathogens to clinical syndrome.

Discussion

Acute respiratory infections may be caused by viruses, bacteria, or both. Thus, determination of the causative agent is crucial to limit the abuse of antibiotics. In our study conducted over a period of 1 year, we showed that viruses were the most common pathogens detected in ARIs. Similar findings have also been reported in a study conducted in United States by Obasi et al[12] in 2013. Several studies conducted in other countries such as Burkina Faso,[10] Zambia,[9] and Niger[13] provided evidence of the role of viruses in upper and lower airway diseases. In Senegal, adenovirus was the most common pathogen detected from ARIs in children. This study confirms previous results reported between 2013 and 2015 in Senegal by Niang et al.[14] The overall detection rate of adenovirus was 50% among the 162 selected children. This adenovirus infection prevalence seems very high compared with rates documented from other countries, namely, Ghana,[15] Burkina,[10] and Zambia.[9] However, our results are in agreement with data reported in Cameroon. Overall, this confirms the overall high prevalence of adenovirus ARI in Africa.[16] In addition to adenovirus, influenza virus, rhinovirus, and enterovirus are the most common viruses detected, as reported in other studies.[10,17] Our study revealed viral codetection is frequent in ARIs. Similar results were found in other countries.[9,10,15] Viral codetection in clinical settings is becoming more common since the introduction of molecular-based multiplex tests. Although the clinical significance of these findings remains unclear, this seems to have no impact in disease severity.[18] In this study, we also found that ARIs were associated with bacterial pathogens; among those, S. pneumoniae (17.9%), M. catarrhalis (15.43%), and H. influenzae (8%) were the most common. In contrast with our findings, high rate (56%) of S. pneumoniae detection was observed in Niger among children having ARIs.[13] In our study, prevalence of mono-infections with S. pneumoniae (2%), M. catarrhalis (2%), or H. influenzae (1%) was very low. Thus, this low prevalence of bacterial pathogens in ARIs proves that antibiotics should no longer be systematically used in the treatment of ARIs. However, among low-prevalence bacterial isolates, codetections with viruses were more frequent and S. pneumoniae (16, 6%) coinfection was the most frequent in our findings. Similar results were reported in other studies.[19,20] There results highlight the pivotal role of viruses in ARIs because primary infection with viral pathogens can predispose children to subsequent bacterial infections.[21] Our study has limitations; among others, the sample size which does not really allow to determine the direct association between viral or bacterial infection and disease severity. Moreover, a case-control study would be more suitable to determine the exact role of viruses in ARIs pathogenesis. In conclusion, this study reports the profile of viral and bacterial pathogens among children under 5 years hospitalized with ARIs in Senegal. The high prevalence rates of viral infections and its clinical impact highlight the need to implement a systematic surveillance program for a better management of ARIs in children, particularly in resource-limited settings.
  17 in total

1.  High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia.

Authors:  Nicole Wolter; Stefano Tempia; Cheryl Cohen; Shabir A Madhi; Marietjie Venter; Jocelyn Moyes; Sibongile Walaza; Babatyi Malope-Kgokong; Michelle Groome; Mignon du Plessis; Victoria Magomani; Marthi Pretorius; Orienka Hellferscee; Halima Dawood; Kathleen Kahn; Ebrahim Variava; Keith P Klugman; Anne von Gottberg
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

2.  Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.

Authors:  Patrick D Mauldin; Cassandra D Salgado; Ida Solhøj Hansen; Darshana T Durup; John A Bosso
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

3.  Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex).

Authors:  J Fan; K J Henrickson; L L Savatski
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

4.  Viral and atypical bacterial detection in acute respiratory infection in children under five years.

Authors:  Patrícia G M Bezerra; Murilo C A Britto; Jailson B Correia; Maria do Carmo M B Duarte; Angela M Fonceca; Katie Rose; Mark J Hopkins; Luis E Cuevas; Paul S McNamara
Journal:  PLoS One       Date:  2011-04-18       Impact factor: 3.240

5.  Respiratory viruses in children hospitalized for acute lower respiratory tract infection in Ghana.

Authors:  Theophilus B Kwofie; Yaw A Anane; Bernard Nkrumah; Augustina Annan; Samuel B Nguah; Michael Owusu
Journal:  Virol J       Date:  2012-04-10       Impact factor: 4.099

6.  Identification of viral and bacterial pathogens from hospitalized children with severe acute respiratory illness in Lusaka, Zambia, 2011-2012: a cross-sectional study.

Authors:  Paul Simusika; Allen C Bateman; Andros Theo; Geoffrey Kwenda; Christine Mfula; Edward Chentulo; Mwaka Monze
Journal:  BMC Infect Dis       Date:  2015-02-12       Impact factor: 3.090

7.  Viral etiology of respiratory tract infections in children at the pediatric hospital in Ouagadougou (Burkina Faso).

Authors:  Solange Ouédraogo; Blaise Traoré; Zah Ange Brice Nene Bi; Firmin Tiandama Yonli; Donatien Kima; Pierre Bonané; Lassané Congo; Rasmata Ouédraogo Traoré; Diarra Yé; Christophe Marguet; Jean-Christophe Plantier; Astrid Vabret; Marie Gueudin
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

8.  Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction.

Authors:  Mohamed S Al-Ayed; Ahmed M Asaad; Mohamed A Qureshi; Mohammed S Ameen
Journal:  Saudi Med J       Date:  2014-11       Impact factor: 1.484

9.  Development of three multiplex RT-PCR assays for the detection of 12 respiratory RNA viruses.

Authors:  S Bellau-Pujol; A Vabret; L Legrand; J Dina; S Gouarin; J Petitjean-Lecherbonnier; B Pozzetto; C Ginevra; F Freymuth
Journal:  J Virol Methods       Date:  2005-06       Impact factor: 2.014

10.  Viral and bacterial etiology of severe acute respiratory illness among children < 5 years of age without influenza in Niger.

Authors:  Adamou Lagare; Halima Boubacar Maïnassara; Bassira Issaka; Ali Sidiki; Stefano Tempia
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

View more
  11 in total

1.  Identification of pathogens from the upper respiratory tract of adult emergency department patients at high risk for influenza complications in a pre-Sars-CoV-2 environment.

Authors:  Justin Hardick; Kathryn Shaw-Saliba; Breana McBryde; Charlotte A Gaydos; Yu-Hsiang Hsieh; Frank Lovecchio; Mark Steele; David Talan; Richard E Rothman
Journal:  Diagn Microbiol Infect Dis       Date:  2021-02-17       Impact factor: 2.803

2.  Nasal colonization by potential bacterial pathogens in healthy kindergarten children of Nepal: a prevalence study.

Authors:  Govinda Paudel; Neetu Amatya; Bhuvan Saud; Sunita Wagle; Vikram Shrestha; Bibhav Adhikari
Journal:  Germs       Date:  2022-03-31

3.  Influenza-like illness is associated with high pneumococcal carriage density in Malawian children.

Authors:  Tinashe K Nyazika; Alice Law; Todd D Swarthout; Lusako Sibale; Danielle Ter Braake; Neil French; Robert S Heyderman; Dean Everett; Aras Kadioglu; Kondwani C Jambo; Daniel R Neill
Journal:  J Infect       Date:  2020-07-22       Impact factor: 6.072

4.  VIRAL ETIOLOGY AND OUTCOME OF SEVERE LOWER RESPIRATORY TRACT INFECTIONS AMONG CRITICALLY ILL CHILDREN ADMITTED TO THE PICU.

Authors:  Muhterem Duyu; Zeynep Karakaya
Journal:  Med Intensiva (Engl Ed)       Date:  2020-05-13

5.  Etiologies of severe acute respiratory infection (SARI) and misdiagnosis of influenza in Indonesia, 2013-2016.

Authors:  Abu Tholib Aman; Tri Wibawa; Herman Kosasih; Rizka Humardewayanti Asdie; Ida Safitri; Umi Solekhah Intansari; Yuli Mawarti; Pratiwi Sudarmono; Mansyur Arif; Dwiyanti Puspitasari; Bachti Alisjahbana; Ketut Tuti Merati Parwati; Muhammad Hussein Gasem; Dewi Lokida; Nurhayati Lukman; Teguh Sarry Hartono; Yan Mardian; C Jason Liang; Sophia Siddiqui; Muhammad Karyana; Chuen-Yen Lau
Journal:  Influenza Other Respir Viruses       Date:  2020-07-14       Impact factor: 4.380

6.  Aetiology of childhood pneumonia in low- and middle-income countries in the era of vaccination: a systematic review.

Authors:  Claire von Mollendorf; Daria Berger; Amanda Gwee; Trevor Duke; Stephen M Graham; Fiona M Russell; E Kim Mulholland
Journal:  J Glob Health       Date:  2022-07-23       Impact factor: 7.664

7.  Molecular characterization of human adenovirus associated with acute respiratory infections in Cameroon from 2011 to 2014.

Authors:  Sebastien Kenmoe; Marie-Astrid Vernet; Jerôme Le Goff; Véronique Beng Penlap; Astrid Vabret; Richard Njouom
Journal:  Virol J       Date:  2018-10-03       Impact factor: 4.099

8.  Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau.

Authors:  Kristoffer Jarlov Jensen; Sofie Biering-Sørensen; Johan Ursing; Poul-Erik Lund Kofoed; Peter Aaby; Christine Stabell Benn
Journal:  BMJ Glob Health       Date:  2020-03-05

9.  Pathogens Causing Respiratory Tract Infections in Children Less Than 5 Years of Age in Senegal.

Authors:  Rebecca B Knobbe; Abdallah Diallo; Amary Fall; Aida D Gueye; Assane Dieng; Tabitha D van Immerzeel; Abou Ba; Amadou Diop; Abdoulaye Diop; Mbayame Niang; Cheikh Sb Boye
Journal:  Microbiol Insights       Date:  2019-12-30

10.  Field evaluation of a mobile biosafety laboratory in Senegal to strengthen rapid disease outbreak response and monitoring.

Authors:  Cheikh Fall; Aurélie Cappuyns; Oumar Faye; Steven Pauwels; Gamou Fall; Ndongo Dia; Moussa M Diagne; Cheikh T Diagne; Makhtar Niang; Alassane Mbengue; Martin Faye; Idrissa Dieng; Babacar Gningue; Abdoulaye Bousso; Ousmane Faye; Rudi Pauwels; Amadou A Sall
Journal:  Afr J Lab Med       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.